Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-25

Clinical Trial Update: Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids

View source ↗

Summary

This completed clinical trial investigates how glucocorticoids alter the muscle secretome and contribute to muscle atrophy in Cushing syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Cushing Syndrome | Status: COMPLETED